Skip Nav Destination
Issues
Cancer Research
Table of Contents
Advances in Brief
ΔNp63α and TAp63α Regulate Transcription of Genes with Distinct Biological Functions in Cancer and Development1
Guojun Wu; Shuji Nomoto; Mohammad Obaidul Hoque; Tatiana Dracheva; Motonabu Osada; Chyi-Chia Richard Lee; Seung Myung Dong; Zhongmin Guo; Nicole Benoit; Yoram Cohen; Peggy Rechthand; Joseph Califano; Chul-so Moon; Edward Ratovitski; Jin Jen; David Sidransky; Barry Trink
Adenoviral Gene Transfer of Tumor Necrosis Factor-related Apoptosis-Inducing Ligand Overcomes an Impaired Response of Hepatoma Cells but Causes Severe Apoptosis in Primary Human Hepatocytes1
Sorin Armeanu; Ulrich M. Lauer; Irina Smirnow; Martin Schenk; Thomas S. Weiss; Michael Gregor; Michael Bitzer
Biochemistry and Biophysics
Carcinogenesis
Clinical Investigations
Endocrinology
Epidemiology and Prevention
Experimental Therapeutics
Synergistic Down-Regulation of Urokinase Plasminogen Activator Receptor and Matrix Metalloproteinase-9 in SNB19 Glioblastoma Cells Efficiently Inhibits Glioma Cell Invasion, Angiogenesis, and Tumor Growth1
Sajani S. Lakka; Christopher S. Gondi; Niranjan Yanamandra; Dzung H. Dinh; William C. Olivero; Meena Gujrati; Jasti S. Rao
Use of a Vaccine Strain of Measles Virus Genetically Engineered to Produce Carcinoembryonic Antigen as a Novel Therapeutic Agent against Glioblastoma Multiforme1
Loi K. Phuong; Cory Allen; Kah-Whye Peng; Caterina Giannini; Suzanne Greiner; Cynthia J. TenEyck; Prasanna K. Mishra; Slobodan I. Macura; Stephen J. Russell; Evanthia C. Galanis
High-Resolution Magnetic Resonance Imaging of the Efficacy of the Cytosine Analogue 1-[2-C-Cyano-2-deoxy-β-d-arabino-pentofuranosyl]-N4-palmitoyl Cytosine (CS-682) in a Liver-Metastasis Athymic Nude Mouse Model1
Ming Wu; Richard Mazurchuk; Neeta D. Chaudhary; Joseph Spernyak; Jean Veith; Paula Pera; William Greco; Robert M. Hoffman; Tomowo Kobayashi; Ralph J. Bernacki
Local Intracerebral Delivery of Endogenous Inhibitors by Osmotic Minipumps Effectively Suppresses Glioma Growth in Vivo1
Carlo Giussani; Giorgio Carrabba; Mauro Pluderi; Valeria Lucini; Marilou Pannacci; Dario Caronzolo; Francesco Costa; Matteo Minotti; Giustino Tomei; Roberto Villani; Andreas Bikfalvi; Lorenzo Bello
Identification of the Human IAI.3B Promoter Element and Its Use in the Construction of a Replication-selective Adenovirus for Ovarian Cancer Therapy1
Katsuyuki Hamada; Shohei Kohno; Mari Iwamoto; Hiroko Yokota; Masato Okada; Masatoshi Tagawa; Susumu Hirose; Kenshi Yamasaki; Yuji Shirakata; Koji Hashimoto; Masaharu Ito
Immunology
Lack of Terminally Differentiated Tumor-specific CD8+ T Cells at Tumor Site in Spite of Antitumor Immunity to Self-Antigens in Human Metastatic Melanoma1
Roberta Mortarini; Adriano Piris; Andrea Maurichi; Alessandra Molla; Ilaria Bersani; Aldo Bono; Cesare Bartoli; Mario Santinami; Claudia Lombardo; Fernando Ravagnani; Natale Cascinelli; Giorgio Parmiani; Andrea Anichini
Molecular Biology and Genetics
Tumor Classification Based on Gene Expression Profiling Shows That Uveal Melanomas with and without Monosomy 3 Represent Two Distinct Entities1
Frank Tschentscher; Johannes Hüsing; Tanja Hölter; Elisabeth Kruse; Irina Gana Dresen; Karl-Heinz Jöckel; Gerasimos Anastassiou; Harald Schilling; Norbert Bornfeld; Bernhard Horsthemke; Dietmar Rudolf Lohmann; Michael Zeschnigk
p53 Interacts with hRAD51 and hRAD54, and Directly Modulates Homologous Recombination12
Steven P. Linke; Sagar Sengupta; Nissim Khabie; Beth A. Jeffries; Sabine Buchhop; Stefan Miska; Wilhelm Henning; Remy Pedeux; Xin W. Wang; Lorne J. Hofseth; Qin Yang; Susan H. Garfield; Horst-Werner Stürzbecher; Curtis C. Harris
A Transforming Growth Factorβ1 Signal Peptide Variant Increases Secretion in Vitro and Is Associated with Increased Incidence of Invasive Breast Cancer1
Alison M. Dunning; Peter D. Ellis; Simon McBride; Heidi L Kirschenlohr; Catherine S. Healey; Paul R. Kemp; Robert N. Luben; Jenny Chang-Claude; Arto Mannermaa; Vesa Kataja; Paul D. P. Pharoah; Douglas F. Easton; Bruce A. J. Ponder; James C. Metcalfe
Osteoblast-related Transcription Factors Runx2 (Cbfa1/AML3) and MSX2 Mediate the Expression of Bone Sialoprotein in Human Metastatic Breast Cancer Cells1
George L. Barnes; Amjad Javed; Sylvan M. Waller; Mohammad H. Kamal; Kerri E. Hebert; Mohammad Q. Hassan; Akeila Bellahcene; Andre J. van Wijnen; Marian F. Young; Jane B. Lian; Gary S. Stein; Louis C. Gerstenfeld
Tumor Biology
3′-[18F]Fluoro-3′-Deoxythymidine ([18F]-FLT) as Positron Emission Tomography Tracer for Imaging Proliferation in a Murine B-Cell Lymphoma Model and in the Human Disease
Martin Wagner; Ulrike Seitz; Andreas Buck; Bernd Neumaier; Stefan Schultheiß; Markus Bangerter; Martin Bommer; Frank Leithäuser; Edgar Wawra; Gerd Munzert; Sven N. Reske
Genetic Reversion in an Acute Myelogenous Leukemia Cell Line from a Fanconi Anemia Patient with Biallelic Mutations in BRCA21
Hideyuki Ikeda; Maiko Matsushita; Quinten Waisfisz; Akitoshi Kinoshita; Anneke B. Oostra; Aggie W. M. Nieuwint; Johan P. de Winter; Maureen E. Hoatlin; Yohko Kawai; Masao S. Sasaki; Alan D. D’Andrea; Yutaka Kawakami; Hans Joenje
Virology
Seroreactivity to Epidermodysplasia Verruciformis-related Human Papillomavirus Types Is Associated with Nonmelanoma Skin Cancer1
Mariet C. W. Feltkamp; René Broer; Franca M. di Summa; Linda Struijk; Els van der Meijden; Bert P. J. Verlaan; Rudi G. J. Westendorp; Jan ter Schegget; Willy J. M. Spaan; Jan Nico Bouwes Bavinck
Letters to the Editor
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds